Trials / Completed
CompletedNCT02819739
Impact of Hyperoxia During Cardiopulmonary
Impact of Hyperoxia During Cardiopulmonary Bypass in the Occurrence of Cardiovascular Complications After Cardiac Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 330 (actual)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis implies that this work is the use of hyperoxia during cardiopulmonary bypass by his heart preconditioning effect is associated with a lower incidence of cardiac arrhythmias (atrial fibrillation, tachycardia or ventricular fibrillation) and lesions of myocardial ischemia-reperfusion injury in cardiac surgery postoperative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | medical oxygen |
Timeline
- Start date
- 2014-11-11
- Primary completion
- 2018-10-10
- Completion
- 2019-03-30
- First posted
- 2016-06-30
- Last updated
- 2019-04-10
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02819739. Inclusion in this directory is not an endorsement.